American Urogynecologic Society

Medical professional community for individuals and companies in the field of urogynecology

Based in DC

🤖

AI Overview

With $380K in lobbying spend across 28 quarterly filings, American Urogynecologic Society is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2018 to 2024.

$380K
Total Spend
7
Years Active
1
Firms Hired
1
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$40K
2019$40K
2020$50K
2021$40K
2022$60K
2023$80K
2024$70K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues

  • -- H.R. 1892 - Continuing Resolution: Changes to the Medicare Access and CHIP Reauthorization Act of 2016 regarding CMS flexibility for cost measures, penalties, Part B drugs, and PTAC
  • -- H.R. 3358 / S. 1771 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; H.R. 1892 - Continuing Resolution; H.R. 1625 - Vehicle for Conso
  • -- House Subcommittee Draft / S. 3158: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019: Federal research funding for pelvic floor disorder
  • -- H.R. 6740 / S. 3158 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; H.R.6157 - Department of Defense and Labor, Health and Human Ser
  • -- CY 2019 Proposed Medicare Fee Schedule - Proposal regarding office visit documentation and payments; congressional letters to Centers for Medicare and Medicaid Services.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.